#1 Attorneys Network
Collas Crill has advised on the establishment of BioMedInvest III, BioMedPartners’ third Guernsey-domiciled equity venture capital fund, closing at CHF75m.
BioMedInvest III LP is a collective investment scheme authorised by the Guernsey Financial Services Commission. It is the third Guernsey-domiciled BioMedPartners fund, administered by Louvre Fund Services.
The fund is a healthcare venture capital fund which invests in private early-to-mid-stage companies in Switzerland, Germany and neighbouring countries of the EU.
The Collas Crill team comprised of group partner and investment fund specialist Paul Wilkes and associate Alex Wickens.
The post Collas Crill advises on healthcare venture fund appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.
#1 Attorneys Search Engine